RETRACTION
Published on 04 Sep 2023
Retraction: A deep insight into CAR-T cell therapy in non-Hodgkin lymphoma: application, opportunities, and future directions
doi 10.3389/fimmu.2023.1285110
- 1,747 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Novel Therapies for Indolent Lymphomas in the Cellular Therapy Era
Novel Therapies for Indolent Lymphomas in the Cellular Therapy Era
28k
Total downloads
85k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 04 Jan 2023
Safety and efficacy of dual PI3K-δ, γ inhibitor, duvelisib in patients with relapsed or refractory lymphoid neoplasms: A systematic review and meta-analysis of prospective clinical trials
doi 10.3389/fimmu.2022.1070660
- 3,268 views
- 13 citations
CLINICAL TRIAL
Published on 19 Dec 2022
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies
doi 10.3389/fimmu.2022.1074740
- 7,028 views
- 15 citations
REVIEW
Published on 14 Dec 2022
Biology and clinical relevance of follicular cytotoxic T cells
doi 10.3389/fimmu.2022.1036616
- 6,867 views
- 3 citations
ORIGINAL RESEARCH
Published on 05 Dec 2022
Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma
doi 10.3389/fimmu.2022.1004475
- 2,825 views
- 3 citations
SYSTEMATIC REVIEW
Published on 11 Nov 2022
Efficacy and safety of copanlisib in relapsed/refractory B-cell non-Hodgkin lymphoma: A meta-analysis of prospective clinical trials
doi 10.3389/fimmu.2022.1034253
- 2,579 views
- 7 citations
ORIGINAL RESEARCH
Published on 05 Sep 2022
Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma
doi 10.3389/fimmu.2022.997589
- 3,911 views
- 15 citations
REVIEW
Published on 22 Jul 2022
CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
doi 10.3389/fimmu.2022.925985
- 31,311 views
- 96 citations
REVIEW
Published on 23 Jun 2021
RETRACTED: A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
doi 10.3389/fimmu.2021.681984
- 19,205 views
- 39 citations
CASE REPORT
Published on 31 Mar 2021
Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma
doi 10.3389/fimmu.2021.634559
- 2,904 views
- 8 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- T Cell Biology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 85kTopic views
- 56kArticle views
- 28kArticle downloads